Tailored Prednisone Reduction in Preventing Hyperglycemia in Participants With B-Cell Non-Hodgkin Lymphoma Receiving Combination Chemotherapy Treatment
Clinical trial NCT03505762 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03505762
- Sponsor
- Wake Forest University Health Sciences
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-19
- Primary completion
- 2024-03-28
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.